Sponsor

Adagene Inc

Clinical research sponsor

Published trials3

Recruiting shown1

Roles1

SourceClinicalTrials.gov

Clinical trials

3 shown

Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast CancerNCT05491083 · collaborator · 2023-06-12

RECRUITING

A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast CancerNCT05275777 · collaborator · 2022-05-19

ACTIVE_NOT_RECRUITING

A Study to Evaluate the Combination of Nivolumab With ADG106 in Metastatic NSCLCNCT05236608 · collaborator · 2021-11-12

UNKNOWN

Sponsor roles

collaborator3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.